Health & Safety Industry Today

Peripheral Arterial Disease (PAD) Market Projected to Hit USD 9 Billion by 2035, at an Exceptional 5.2% CAGR

Peripheral Arterial Disease (PAD) Market CAGR (growth rate) is expected to be around 5.2% during the forecast period (2025 - 2035).
Published 20 October 2025

WiseGuy Reports, Oct. 2025 (Press Release) – The Peripheral Arterial Disease (PAD) Market Global Outlook:

Global Peripheral Arterial Disease (PAD) Market Growth Analysis and Trends Report Diagnosis Type (Ankle-Brachial Index, Ultrasound, Angiography, Magnetic Resonance Angiography, Computed Tomography Angiography), By Treatment Type (Medications, Surgical Procedures, Endovascular Procedures, Lifestyle Modifications), By Procedure Type (Peripheral Angioplasty, Stenting, Bypass Surgery, Thrombolysis), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories) and By Regions - Global Industry Forecast 2025 to 2035

Peripheral Arterial Disease (PAD) Market Overview

Peripheral Arterial Disease (PAD) Market Set for Significant Growth Amid Rising Diabetes Prevalence

The Peripheral Arterial Disease (PAD) Market is witnessing steady growth due to increasing prevalence of diabetes, an aging global population, and growing demand for minimally invasive vascular procedures. Valued at USD 5.15 billion in 2024, the market is expected to reach USD 5.42 billion in 2025 and expand to USD 9.0 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period. B2B stakeholders, including device manufacturers, hospitals, outpatient centers, and diagnostic companies, are leveraging the rising need for advanced PAD management solutions to strengthen their market position.

The market is driven by technological advancements in diagnostic and treatment devices. Minimally invasive procedures such as angioplasty, stenting, and atherectomy are increasingly preferred over conventional surgery due to reduced recovery time and lower complication risks. Additionally, advanced imaging technologies, catheter-based interventions, and smart therapeutic devices are improving treatment efficacy. Hospitals and vascular centers are actively adopting these innovations to optimize patient outcomes while maintaining cost efficiency.

🔥 Sample report on Peripheral Arterial Disease (PAD) Market: https://www.wiseguyreports.com/sample-request?id=735882

Segmentation of the Peripheral Arterial Disease (PAD) Market includes diagnosis type, treatment type, procedure type, end user, and region. Diagnosis types cover ankle-brachial index (ABI), ultrasound imaging, angiography, and advanced vascular scans. Treatment types include endovascular interventions, surgical bypass, pharmacotherapy, and combination therapies. Procedure types focus on balloon angioplasty, stent placement, atherectomy, and thrombolysis. End users encompass hospitals, specialized vascular centers, outpatient clinics, and diagnostic laboratories. Regionally, North America leads due to advanced healthcare infrastructure, high PAD awareness, and strong regulatory support. Europe is witnessing steady growth with rising adoption of minimally invasive techniques, while APAC presents significant opportunities driven by growing geriatric population, increasing diabetes prevalence, and improving healthcare accessibility. South America and MEA are emerging markets with expanding investment in vascular care infrastructure.

Key companies profiled in the Peripheral Arterial Disease (PAD) Market include Terumo Corporation, Cook Medical, Surmodics, Johnson & Johnson, Asahi Intecc, C.R. Bard, Bayer AG, Stryker Corporation, Abbott Laboratories, Medtronic, Philips, Cardinal Health, AngioDynamics, Boston Scientific, Covidien, and Penumbra. These companies are actively focusing on product innovation, strategic partnerships, and market expansion to gain competitive advantage. B2B collaborations between device manufacturers and healthcare providers play a critical role in clinical trials, training, and adoption of advanced PAD interventions.

Opportunities in the market are largely driven by rising geriatric population demands, increased awareness of PAD symptoms, and advancements in minimally invasive procedures. Hospitals and vascular centers are increasingly adopting endovascular devices due to their safety, efficiency, and improved patient outcomes. Additionally, the expansion of telemedicine services for PAD monitoring and management is opening new avenues for healthcare providers and device manufacturers alike.

👉 Purchase Full Report Here: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735882

The market is further driven by preventive care initiatives and early PAD detection programs. Increasing awareness among patients and healthcare providers about PAD risk factors, including diabetes, hypertension, and smoking, is encouraging early intervention. Integration of wearable devices and remote monitoring solutions into PAD management is improving patient adherence and facilitating timely interventions.

Moreover, hospitals and outpatient centers are investing in specialized vascular teams equipped with cutting-edge diagnostic and treatment technologies. This is fostering the adoption of advanced therapeutic devices and innovative solutions for PAD management. Manufacturers offering customizable and easy-to-use devices are expected to capture additional market share, particularly in regions with rising healthcare expenditure.

Complete Market Details: https://www.wiseguyreports.com/reports/peripheral-arterial-disease-pad-market

Reasons To Buy The Peripheral Arterial Disease (PAD) Market Report:

➼ In-depth analysis of the Peripheral Arterial Disease (PAD) Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Other Related Reports from Latest WiseGuy Reports:

 Epirubicin Hydrochloride Injection Market

Gastroesophageal Reflux Disease GERD Drugs Devices Market

Full Core Biopsy Instrument Market

Gamithromycin Market

GC MS Consumables Market

Familial Chylomicronemia Syndrome Therapeutics Market

Fluorescent DNA Dye Market

General Examination Chair Market

Exosome Analysis Service Market

Gelling Fibre Dressings Market

Gel and Lotion Warmers Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets


Other Industry News

Ready to start publishing

Sign Up today!